Cervical Health

The FDA cleared the Onclarity HPV Self-Collection Kit, allowing patients to collect samples at home for processing via the FDA-cleared BD Onclarity HPV Assay and BD COR System.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

Research published in The BMJ indicates that individuals vaccinated against HPV before age 17 experience a 79% reduction in invasive cervical cancer risk compared to unvaccinated peers.

A Chinese study found that menstrual blood HPV testing had a comparable diagnostic accuracy to clinician-collected cervical samples in detecting CIN2+ and CIN3+.

Take a quick look at everything you may have missed in January, from our latest video interviews to new clinical trial data to a FAQ on cervical cancer.

Federal guidance now designates primary hrHPV testing every 5 years as the preferred cervical cancer screening method for most average-risk women aged 30 to 65 years and adds patient self-collection as an acceptable option.

New HRSA guidelines strengthen cervical cancer prevention by adding self-collected hrHPV testing and clarifying no-cost coverage for additional diagnostic services.

A study found HPV vaccination is linked to reduced odds of severe vulvar and vaginal precancerous lesions.

A study found widespread nonadherence to cervical cancer screening guidelines, with screening modality linked to overscreening and underscreening.

A study found women aged 65 years and older had significantly greater odds of late-stage cervical cancer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Researchers found that raising screening rates in federally qualified health centers to national goals could prevent thousands of cancers.

Declining national screening rates highlight the need for increased investment, education, and innovative approaches to expand access.

A new study shows that directly mailing human papillomavirus self-sampling kits improves screening adherence and offers superior cost-effectiveness.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A study found that recommended treatment significantly increases survival rates in women aged 65 years and older with early-stage cervical cancer.

New research reveals rising non-adherence to cervical cancer screening and declining HPV vaccine awareness since the pandemic.

New research suggests women with a history of cervical cancer face elevated anal cancer risk, highlighting the need for expanded screening guidelines.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A study found women with Medicaid insurance are more than twice as likely to experience delays in starting cervical cancer treatment.